Guanfacine extended-release
NDC 70518-4266, guanfacine, tablet, extended release, from REMEDYREPACK INC..
- Product NDC
- 70518-4266
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205430
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-4266-0 | 70518426600 | 100 POUCH in 1 BOX (70518-4266-0) / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-4266-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8348e63a-5cbc-489e-b7bf-046c65ba2e8e
Use it
Look up 70518-4266 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-4266. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.